In VivoGene Therapy with a Cationic Polymer Markedly Enhances the Antitumor Activity of Antiangiogenic Genes

This publication has 14 references indexed in Scilit:

• Gene Therapy with P53 and a Fragment of Thrombospondin I Inhibits Human Breast Cancerin Vivo
  Molecular Genetics and Metabolism, 1998
• Parenteral Gene Therapy with p53 Inhibits Human Breast TumorsIn VivoThrough a Bystander Mechanism Without Evidence of Toxicity
  Human Gene Therapy, 1997
• A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
  Proceedings of the National Academy of Sciences, 1995
• Systemic Gene Therapy with p53 Reduces Growth and Metastases of a Malignant Human Breast Cancer in Nude Mice
  Human Gene Therapy, 1995
• Inhibition of Human Ovarian Carcinoma Cell Proliferation by Liposome-Plasmid DNA Complex
  Biochemical and Biophysical Research Communications, 1995
• Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
  Cell, 1994
• The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
  Endocrinology, 1993
• Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
  The Journal of cell biology, 1993
• Systemic Gene Expression After Intravenous DNA Delivery into Adult Mice
  Science, 1993
• Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides
  Science, 1990